Robert Aberman is an experienced executive with a robust background in finance and healthcare management. Serving as President at MedsByMe from July 2019 to October 2021, Robert led the development of a groundbreaking marketplace for prescription medication. Prior to this, leadership roles included Managing Director at Jefferies & Company and Senior Managing Director at Bear Stearns, along with various key positions at Merrill Lynch and JP Morgan. Currently, Robert holds the position of Director, Population Health at GeneID Lab, Advanced Molecular Diagnostics, and has previously contributed to Dialyze Direct and Compassionate Care Hospice in multiple capacities, focusing on hospital relations and business development. Educational qualifications include a BSc in Finance from The Wharton School and an MBA in Finance from Columbia Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices